Spain, July 21 -- Spain based NOVO NORDISK PHARMA, S.A. has secured contract from Servicio Murciano de Salud - Junta de Compras for Medicinal products for the blood, blood-forming organs and the cardiovascular system - Supply of medications with active ingredient Recombinant coagulation factor VIII . The value of the contract is worth 456000 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....